Our results confirmed that the cytokine and S. aureus infection-associated psoriasis groups were characterized by a significant increase of IL-1β, IL-2, and IL-12 expression; however, the treatments with melatonin at 10 nM and 50 nM were able to significantly decrease their expression, reducing inflammatory response. The gene discussed is IL2; the disease is psoriasis.